72 research outputs found

    The effectiveness of home versus community-based weight control programmes initiated soon after breast cancer diagnosis:a randomised controlled trial

    Get PDF
    Background: Breast cancer diagnosis may be a teachable moment for lifestyle behaviour change and to prevent adjuvant therapy associated weight gain. We assessed the acceptability and effectiveness of two weight control programmes initiated soon after breast cancer diagnosis to reduce weight amongst overweight or obese women and prevent gains in normal-weight women. Methods: Overweight or obese (n = 243) and normal weight (n = 166) women were randomised to a three-month unsupervised home (home), a supervised community weight control programme (community) or to standard written advice (control). Primary end points were change in weight and body fat at 12 months. Secondary end points included change in insulin, cardiovascular risk markers, quality of life and cost-effectiveness of the programmes. Results: Forty-three percent of eligible women were recruited. Both programmes reduced weight and body fat: home vs. control mean (95% CI); weight −2.3 (−3.5, −1.0) kg, body fat −1.6 (−2.6, −0.7) kg, community vs. control; weight −2.4 (−3.6, −1.1) kg, body fat −1.4 (−2.4, −0.5) kg (all p &lt; 0.001). The community group increased physical activity, reduced insulin, cardiovascular disease risk markers, increased QOL and was cost-effective. Conclusions: The programmes were equally effective for weight control, but the community programme had additional benefits. Clinical trial registration: ISRCTN68576140.</p

    Supplement use during an intergroup clinical trial for breast cancer (S0221)

    Get PDF
    The use of supplements during chemotherapy is controversial, partly due to the potential effect of antioxidants on reduced efficacy of chemotherapy-related cytotoxicity. We examined supplement use among breast cancer patients registered to a clinical trial (SWOG 0221) before diagnosis and during treatment. Patients (n = 1,467) completed questionnaires regarding multivitamin and supplement use at trial registration (baseline) to capture use before diagnosis. Of these patients, 1,249 completed a 6-month followup questionnaire to capture use during treatment. We examined the use of vitamins C, D, E, B6, B12, folic acid, and calcium at these timepoints, as well as physician recommendations regarding supplement use. The use of vitamins C, E, folic acid, and calcium decreased during treatment, while the use of vitamin B6 increased. Five hundred seventy four patients (51 %) received no physician recommendations regarding supplement use. Among the remaining 49, 10 % were advised not to take multivitamins and/or supplements, 7 % were advised to use only multivitamins, and 32 % received recommendations to use multivitamins and/or supplements. Among patients who took vitamin C before diagnosis, those who were advised not to take supplements were >5 times more likely not to use of vitamin C during treatment than those not advised to stop use (OR = 5.27, 95 % CI 1.13–24.6). Previous non-users who were advised to take a multivitamin were nearly 5 times more likely to use multivitamins during treatment compared to those who received no recommendation (OR = 4.66, 95 % CI 2.10–10.3). In this clinical trial for high-risk breast cancer, supplement use generally decreased during treatment. Upon followup from the clinical trial, findings regarding supplement use and survival outcomes will better inform physician recommendations for patients on adjuvant chemotherapy

    Determinants of premature mortality in a city population: An eight-year observational study concerning subjects aged 18–64

    Full text link
    Background: Premature deaths constitute 31.1% of all deaths in Łódź. Analysis of the causes of premature deaths may be helpful in the evaluation of health risk factors. Moreover, findings of this study may enhance prophylactic measures. Material and Methods: In 2001, 1857 randomly selected citizens, aged 18-64, were included in the Countrywide Integrated Noncommunicable Diseases Intervention (CINDI) Programme. In 2009, a follow-up study was conducted and information on the subjects of the study was collected concerning their health status and if they continued to live in Łódź. The Cox proportional hazards model was used for evaluation of hazard coefficients. We adjusted our calculations for age and sex. The analysis revealed statistically significant associations between the number of premature deaths of the citizens of Łódź and the following variables: a negative self-evaluation of health - HR = 3.096 (95% CI: 1.729-5.543), poor financial situation - HR = 2.811 (95% CI: 1.183‑6.672), occurring in the year preceding the study: coronary pain - HR = 2.754 (95% CI: 1.167-6.494), depression - HR = 2.001 (95% CI: 1.222-3.277) and insomnia - HR = 1.660 (95% CI: 1.029-2.678). Our research study also found a negative influence of smoking on the health status - HR = 2.782 (95% CI: 1.581-4.891). Moreover, we conducted survival analyses according to sex and age with Kaplan-Meier curves. Conclusions: The risk factors leading to premature deaths were found to be highly significant but possible to reduce by modifying lifestyle-related health behaviours. The confirmed determinants of premature mortality indicate a need to spread and intensify prophylactic activities in Poland, which is a post-communist country, in particular, in the field of cardiovascular diseases

    Breast cancer survival among young women: a review of the role of modifiable lifestyle factors

    Get PDF

    Maternal Adverse Childhood Experiences, Postpartum Healthcare and Depressive Symptoms: Pregnancy Risk Assessment Monitoring System Database, 2016-2022

    No full text
    PURPOSE: Adverse Childhood Experiences (ACEs) are a predictor of adverse outcomes later in life, particularly for maternal health outcomes. This project aimed to evaluate the associations between ACEs and postpartum depressive symptoms (PDS) and utilization of postpartum healthcare. SUBJECTS: We analyzed data from the CDC’s Pregnancy Risk Assessment and Monitoring System for 2016-2022, which is a population-based surveillance system implemented by state health departments among women with a recent live birth. METHODS AND MATERIALS: Our sample was limited to four jurisdictions with data on ACEs (n= 21,160). Self-reported outcomes included postpartum check-up, asked about depression during postpartum visit, and PDS (depressed since birth, no interest since birth). ANALYSES: Multivariable logistic regression models accounting for survey complex weighting were used to estimate odds ratios and 95% confidence intervals (CIs) for the associations of ACEs and postpartum outcomes. RESULTS: Black and low-income mothers experienced more PDS, but were less likely to be asked about depression during a postpartum visit. Women who had certain ACEs were more likely to experience postpartum depression and postpartum lack of interest. In adjusted models, women who had 4 or more ACEs had 2.50 times the odds of having postpartum depression (95% CI: 2.08 - 2.99) and 1.85 times the odds of having no interest since birth (95% CI: 1.58 - 2.16). CONCLUSIONS: Women who had 4 or more ACEs were more likely to have PDS. Providing postpartum support and resources for women with a history of ACEs is critical
    corecore